Excellent biotech news in 2022? BioTech Health X offers you the newest professional biotechnology news including breaking news on the latest biotechnology research, emerging companies, biotech acquisitions, funding deals and other industry analysis. We focus on covering the latest updates in biotech including clinical research, drug development, drug discovery, clinical trials, FDA decisions and other development information regarding the Life Sciences industry.
Toyobo Co., Ltd. has launched a major U.S. marketing initiative for Nerbridge TM (“the product”, hereafter), a conduit for peripheral nerve regeneration. On January 11, 2022, Toyobo kicked off the sales promotion campaign at a conference jointly held in Carlsbad, California, by three societies – the American Association for Hand Surgery (AAHS), the American Society for Peripheral Nerve (ASPN) and the American Society for Reconstructive Microsurgery (ASRM). The campaign is being conducted in partnership with the exclusive U.S. distributor of Nerbridge TM, Synovis Micro Companies Alliance, Inc. (hereafter Synovis), a subsidiary of Baxter International Inc., a global medtech leader. Toyobo plans to enhance the production capacity of the product by the end of 2025 as well as expanding the scope of its clinical applications. To respond to the increasing demand expected for nerves conduits in the U.S. and elsewhere in the world, Toyobo will strengthen its production and sales capacities, thus becoming the leading company in the nerve conduit business field.
CureDuchenne, a company committed to finding a cure for Duchenne muscular dystrophy (DMD), will be holding its FUTURES 2022 conference in Orlando, Florida this May. CureDuchenne’s mission is to extend and improve the lives of everyone affected by Duchenne muscular dystrophy,” CEO Debra Miller told BioSpace. Duchenne is a fatal and progressive muscle wasting disease. It affects primarily boys, although girls can be carriers, so it really does affect the whole family. Miller explained that the boys who suffer are typically confined to a wheelchair by the age of 12. Our mission is to fund transformative and impactful research that stands a good chance of resulting in an approved drug, she continued. We also provide support and resources to the families that are living with this disease.
Our coverage spans research at the university level to Leibniz Institute Sagol Center to Hans Knöll Institute, infection biology to children with rare gene diseases, to the latest new infection that may arise like the risk of a global virus BioTech Health X keeps you up to date with news as it is revealed. Our team helps describe and characterize the new method of treatments like the promising nature of the COVID 19 vaccine. Breakthrough drugs are being made by various research team around the world and the environment in which we live is ever changing. Read more info on https://biotechhealthx.com/.
In terms of regional segmentation, the global passive prosthetics market is divided into five key regions namely Asia Pacific, Europe, Latin America, North America, and the Middle East and Africa. Currently, the North America market is the leading regional segment. The growth of the market is due to the growing awareness about passive prosthetics among the people. Moreover, the early access to the new technologies and products in the market are also helping the passive prosthetics market grow in the region. Other region such as the Middle East and Africa and Europe are showing steady growth of the market in recent years.
